Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
HBIO	HARVARD BIOSCIENCE INC	United States	$157.11M	43,399,291	51.38%	48.62%	Net Selling	Net Selling
HCAT	HEALTH CATALYST INC	United States	$353.13M	58,563,005	74.87%	25.13%	Net Selling	Net Selling
PPBT	PURPLE BIOTECH LTD	Israel	$9.72M	198,386,080	1.23%	0.00%
GHSI	GUARDION HEALTH SCIENCES INC	United States	$10.14M	1,284,156	0.40%	99.60%
ALPN	ALPINE IMMUNE SCIENCES INC	United States	$4.23B	65,546,136	59.43%	40.57%	Net Buying
DMTK	DERMTECH INC	United States	$20.88M	34,623,443	15.75%	77.74%	Net Selling	Net Selling
DNA	GINKGO BIOWORKS HOLDINGS INC	United States	$1.85B	2,152,395,786	58.22%	13.98%	Net Selling	Net Selling
TTNP	TITAN PHARMACEUTICALS INC	United States	$6.48M	914,234	2.50%	97.50%	Net Selling
ETNB	89BIO INC	United States	$772.32M	93,501,210	85.97%	14.03%	Net Buying	Net Buying
TBPH	THERAVANCE BIOPHARMA INC	Cayman Islands	$439.26M	48,164,708	60.28%	39.72%	Net Selling	Net Selling
SRTS	SENSUS HEALTHCARE INC	United States	$55.90M	16,394,171	15.94%	32.93%	Net Buying
RIGL	RIGEL PHARMACEUTICALS INC	United States	$192.92M	175,377,812	60.76%	15.75%	Net Selling	Net Selling
EVGN	EVOGENE LTD	Israel	$31.62M	50,584,588	8.48%	0.00%
SVRA	SAVARA INC	United States	$609.23M	138,148,141	32.26%	67.74%	Net Buying	Net Selling
ABIO	ARCA BIOPHARMA INC	United States	$51.94M	14,507,143	4.98%	95.02%
TCRX	TSCAN THERAPEUTICS INC	United States	$350.50M	47,882,196	66.65%	29.73%	Net Buying
NEO	NEOGENOMICS INC	United States	$1.80B	127,610,039	72.39%	27.61%	Net Selling	Net Selling
ATXS	ASTRIA THERAPEUTICS INC	United States	$494.13M	54,903,061	67.13%	25.09%	Net Buying	Net Buying
DTIL	PRECISION BIOSCIENCES INC	United States	$64.87M	6,916,239	53.55%	46.45%	Net Selling
CABA	CABALETTA BIO INC	United States	$531.14M	48,241,615	92.00%	8.00%	Net Buying
NTBL	NOTABLE LABS LTD	Israel	$8.70M	9,018,261	2.63%	97.37%	Net Selling
OMIC	SINGULAR GENOMICS SYSTEMS INC	United States	$29.87M	73,928,557	35.41%	38.17%	Net Selling
CYCN	CYCLERION THERAPEUTICS INC	United States	$7.94M	2,710,096	9.83%	90.17%	Net Buying
NRC	NATIONAL RESEARCH CORP	United States	$806.52M	23,854,428	49.73%	47.81%	Net Selling	Net Selling
DNTH	DIANTHUS THERAPEUTICS INC	United States	$630.96M	29,346,760	24.91%	75.09%	Net Buying
AKRO	AKERO THERAPEUTICS INC	United States	$1.11B	56,297,528	66.82%	33.18%	Net Buying	Net Buying
LRMR	LARIMAR THERAPEUTICS INC	United States	$410.87M	63,800,017	42.05%	57.95%	Net Buying	Net Buying
TERN	TERNS PHARMACEUTICALS INC	United States	$317.44M	64,651,693	72.52%	27.48%	Net Selling	Net Selling
VTRS	VIATRIS INC	United States	$13.74B	1,187,569,149	80.70%	17.91%	Net Selling	Net Selling
PROF	PROFOUND MEDICAL CORP	Canada	$171.61M	21,370,565	43.20%	0.00%
TRVI	TREVI THERAPEUTICS INC	United States	$191.71M	68,960,167	22.22%	77.78%	Net Buying
DMAC	DIAMEDICA THERAPEUTICS INC	United States	$97.55M	37,958,000	10.12%	55.46%	Net Buying
LFMD	LIFEMD INC	United States	$482.37M	40,366,047	30.83%	53.11%	Net Buying
LABP	LANDOS BIOPHARMA INC	United States	$69.53M	3,116,729	4.53%	95.47%
CRDF	CARDIFF ONCOLOGY INC	United States	$181.84M	44,677,169	11.85%	34.59%	Net Buying
CLPT	CLEARPOINT NEURO INC	United States	$141.90M	26,976,289	23.33%	25.71%	Net Selling	Net Selling
STIM	NEURONETICS INC	United States	$103.85M	29,756,053	50.13%	49.87%	Net Selling	Net Selling
ACAD	ACADIA PHARMACEUTICALS INC	United States	$2.75B	164,771,521	71.22%	28.78%	Net Buying	Net Selling
IRTC	IRHYTHM TECHNOLOGIES INC	United States	$3.47B	30,978,772	77.03%	22.97%	Net Selling	Net Selling
RLAY	RELAY THERAPEUTICS INC	United States	$835.61M	131,179,034	72.36%	27.64%	Net Selling	Net Selling
CLDX	CELLDEX THERAPEUTICS INC	United States	$2.03B	55,900,679	82.75%	17.25%	Net Buying	Net Buying
BPMC	BLUEPRINT MEDICINES CORP	United States	$5.69B	61,232,297	81.64%	18.36%	Net Selling	Net Selling
TELA	TELA BIO INC	United States	$109.69M	24,649,595	47.74%	52.26%	Net Selling	Net Selling
HOWL	WEREWOLF THERAPEUTICS INC	United States	$288.48M	42,737,191	48.08%	51.92%
AVXL	ANAVEX LIFE SCIENCES CORP	United States	$282.47M	82,112,511	31.49%	5.04%	Net Buying	Net Buying
PMCB	PHARMACYTE BIOTECH INC	United States	$17.86M	8,464,824	12.86%	13.29%
NVNO	ENVVENO MEDICAL CORP	United States	$68.98M	13,317,000	27.51%	72.49%	Net Buying	Net Buying
ELVN	ENLIVEN THERAPEUTICS INC	United States	$710.35M	41,347,632	46.22%	53.78%	Net Selling	Net Selling
ATOS	ATOSSA THERAPEUTICS INC	United States	$191.72M	125,304,064	12.74%	15.22%	Net Buying	Net Buying
ICAD	ICAD INC	United States	$39.01M	26,540,030	24.44%	62.73%
TVTX	TRAVERE THERAPEUTICS INC	United States	$400.28M	76,098,485	59.75%	40.25%	Net Selling	Net Selling
IOBT	IO BIOTECH INC	Denmark	$93.55M	65,880,914	36.62%	63.38%	Net Buying	Net Selling
SNSE	SENSEI BIOTHERAPEUTICS INC	United States	$25.57M	25,070,980	11.82%	71.99%	Net Selling	Net Selling
FDMT	4D MOLECULAR THERAPEUTICS INC	United States	$1.16B	49,778,127	83.80%	16.20%	Net Buying	Net Selling
GH	GUARDANT HEALTH INC	United States	$2.11B	121,712,724	64.42%	35.58%	Net Selling	Net Selling
QIPT	QUIPT HOME MEDICAL CORP	United States	$154.09M	42,102,000	43.00%	0.00%
DVAX	DYNAVAX TECHNOLOGIES CORP	United States	$1.46B	130,614,772	71.63%	28.37%	Net Selling	Net Selling
PULM	PULMATRIX INC	United States	$7.45M	3,652,285	4.28%	95.72%
RXRX	RECURSION PHARMACEUTICALS INC	United States	$1.91B	234,653,272	75.27%	24.73%	Net Selling	Net Selling
FOLD	AMICUS THERAPEUTICS INC	United States	$3.04B	295,382,614	66.56%	33.44%	Net Selling	Net Selling
CMAX	CAREMAX INC	United States	$11.86M	3,802,883	49.20%	50.80%
OPTN	OPTINOSE INC	United States	$96.88M	112,651,740	69.22%	30.78%	Net Selling	Net Selling
PACS	PACS GROUP INC	United States	N/A	147,773,386	0.00%	89.85%	Net Selling	Net Selling
PHAR	PHARMING GROUP NV	Netherlands	$657.65M	671,073,243	0.00%	0.00%
OCUL	OCULAR THERAPEUTIX INC	United States	$705.24M	148,627,439	49.43%	21.84%	Net Buying	Net Buying
URGN	UROGEN PHARMA LTD	Israel	$482.83M	34,122,087	62.74%	29.32%	Net Buying	Net Selling
MNKD	MANNKIND CORP	United States	$1.14B	270,418,215	30.01%	69.99%	Net Buying	Net Buying
OCGN	OCUGEN INC	United States	$329.38M	257,325,264	10.16%	11.93%	Net Selling
CDTX	CIDARA THERAPEUTICS INC	United States	$57.61M	4,561,751	61.60%	38.40%	Net Selling	Net Selling
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	United States	$377.24M	145,092,271	62.07%	37.93%	Net Selling	Net Selling
RGEN	REPLIGEN CORP	United States	$9.29B	55,771,075	73.41%	26.59%	Net Selling	Net Selling
ICCM	ICECURE MEDICAL LTD	Israel	$54.88M	45,729,684	0.62%	0.00%
ECOR	ELECTROCORE INC	United States	$34.58M	6,002,628	7.07%	92.93%	Net Buying
PSTX	POSEIDA THERAPEUTICS INC	United States	$205.52M	96,489,127	46.85%	40.59%	Net Selling	Net Selling
CRVO	CERVOMED INC	United States	$146.98M	6,170,479	0.47%	99.53%
TCRT	ALAUNOS THERAPEUTICS INC	United States	$21.14M	16,012,479	53.36%	46.64%	Net Selling
RPTX	REPARE THERAPEUTICS INC	Canada	$134.98M	42,182,177	61.13%	38.87%	Net Buying	Net Selling
AADI	AADI BIOSCIENCE INC	United States	$42.97M	24,554,205	26.93%	73.07%	Net Selling	Net Selling
RGNX	REGENXBIO INC	United States	$719.28M	44,427,555	76.15%	23.85%	Net Selling	Net Buying
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	United States	$1.94B	251,399,871	35.06%	64.94%	Net Selling	Net Selling
RMTI	ROCKWELL MEDICAL INC	United States	$42.68M	29,334,617	13.64%	86.36%	Net Selling	Net Selling
BGLC	BIONEXUS GENE LAB CORP	Malaysia	$10.49M	17,667,663	0.59%	97.91%
MRNA	MODERNA INC	United States	$41.25B	382,073,208	67.30%	21.66%	Net Selling	Net Selling
IPHA	INNATE PHARMA SA	France	$197.92M	80,453,282	0.16%	0.00%
LNSR	LENSAR INC	United States	$36.92M	11,395,056	32.17%	48.15%	Net Buying
BNR	BURNING ROCK BIOTECH LTD	China	$87.04M	102,396,208	19.66%	0.00%
BLFS	BIOLIFE SOLUTIONS INC	United States	$794.11M	45,300,000	58.87%	41.13%	Net Buying	Net Selling
LEXX	LEXARIA BIOSCIENCE CORP	Canada	$30.28M	12,885,673	8.82%	4.82%
CLLS	CELLECTIS SA	France	$139.29M	55,583,768	17.66%	0.00%
SILO	SILO PHARMA INC	United States	$5.26M	2,843,634	5.65%	6.35%	Net Buying	Net Buying
BRTX	BIORESTORATIVE THERAPIES INC	United States	$8.46M	6,769,919	0.28%	99.72%	Net Buying	Net Buying
OTRK	ONTRAK INC	United States	$13.97M	47,667,342	1.19%	98.81%	Net Buying
IMRN	IMMURON LTD	Australia	$15.03M	227,798,346	0.00%	0.00%
TLPH	TALPHERA INC	United States	$17.82M	16,969,103	8.65%	91.35%	Net Buying	Net Buying
CANF	CAN-FITE BIOPHARMA LTD	Israel	$8.08M	1,359,837,393	0.02%	0.00%
HOOK	HOOKIPA PHARMA INC	United States	$88.36M	98,950,107	35.22%	26.83%	Net Buying
EVH	EVOLENT HEALTH INC	United States	$3.19B	115,430,107	89.64%	10.36%	Net Selling	Net Selling
BLRX	BIOLINERX LTD	Israel	$44.55M	1,086,589,165	0.10%	0.00%
OCX	ONCOCYTE CORP	United States	$20.52M	8,273,073	5.82%	94.18%	Net Buying	Net Buying
ZJYL	JIN MEDICAL INTERNATIONAL LTD	China	$646.40M	160,000,000	0.00%	0.00%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+1.20%	+1.13%	-9.62%	-22.18%	14.88x	5.85x	-68.98%	+2.75%	+21.30%	+91.76%	Strong Buy
Diagnostics & Research	66	+0.75%	+4.09%	-5.10%	-0.74%	38.49x	4.18x	-21.75%	+6.53%	+11.20%	+10.85%	Buy
Drug Manufacturers - General	17	+0.34%	+1.38%	-4.08%	+12.78%	159.81x	6.13x	+32.60%	+7.65%	+14.35%	+16.05%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.98%	+2.24%	-2.72%	-6.94%	33.92x	2.09x	+11.56%	+2.78%	+5.22%	+37.77%	Strong Buy
Healthcare Plans	12	-0.85%	-2.11%	-4.78%	+3.59%	18.86x	2.91x	+20.02%	+6.15%	+14.19%	+16.44%	Buy
Health Information Services	61	+0.87%	+0.45%	-8.40%	-24.77%	72.49x	3.38x	+6.61%	+2.33%	+5.91%	+38.22%	Buy
Medical Care Facilities	50	-0.63%	-0.25%	-6.53%	+3.06%	-1.17x	4.49x	-87.35%	+6.17%	+13.08%	+19.34%	Buy
Medical Devices	154	+0.28%	+1.14%	-4.31%	-15.96%	28.63x	3.70x	+10.75%	+5.35%	+7.78%	+22.84%	Buy
Medical Distribution	9	+0.52%	+1.70%	-0.69%	+37.51%	26.24x	147.94x	+18.14%	+3.52%	+19.64%	+3.58%	Buy
Medical Instruments & Supplies	56	+1.23%	+1.70%	-4.37%	-11.53%	48.29x	3.53x	+11.70%	+7.83%	+10.36%	+20.52%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other healthcare stocks by -20 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other healthcare stocks by 3 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.61% over the past year, overperforming other healthcare stocks by 10 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.84%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 55 percentage points higher than the healthcare sector average of 2.84%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.95%, which is 9 percentage points higher than the healthcare sector average of 2.84%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.62% in the last day, and up 1.39% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.25% in the past year. It has underperformed other stocks in the healthcare sector by -30 percentage points.

2. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.19% in the past year. It has underperformed other stocks in the healthcare sector by -43 percentage points.

3. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -19.88% in the past year. It has underperformed other stocks in the healthcare sector by -10 percentage points.

Are healthcare stocks a good buy now?

47.45% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.39% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 74.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.